Investigation of the Importance of Multidrug Resistance-Associated Protein 4 (Mrp4/ Abcc4 ) in the Active Efflux of Anionic Drugs Across the Blood–Brain Barrier
- 1 September 2017
- journal article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 106 (9) , 2566-2575
Abstract
No abstract availableKeywords
Funding Information
- Japan Society for the Promotion of Science (26293032)
This publication has 34 references indexed in Scilit:
- The Effect of ABCG2 and ABCC4 on the Pharmacokinetics of Methotrexate in the BrainDrug Metabolism and Disposition, 2014
- Role of OATP-1B1 and/or OATP-1B3 in hepatic disposition of tyrosine kinase inhibitorsDrug Metabolism and Drug Interactions, 2014
- Limited Brain Distribution of [3R,4R,5S ]-4-Acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate Phosphate (Ro 64-0802), a Pharmacologically Active Form of Oseltamivir, by Active Efflux across the Blood-Brain Barrier Mediated by Organic Anion Transporter 3 (Oat3/Slc22a8) and Multidrug Resistance-Associated Protein 4 (Mrp4/Abcc4)Drug Metabolism and Disposition, 2009
- Multidrug resistance protein 4 (MRP4/ABCC4): a versatile efflux transporter for drugs and signalling moleculesTrends in Pharmacological Sciences, 2008
- P-glycoprotein Restricts the Penetration of Oseltamivir Across the Blood-Brain BarrierDrug Metabolism and Disposition, 2008
- Multichannel Liquid Chromatography–Tandem Mass Spectrometry Cocktail Method for Comprehensive Substrate Characterization of Multidrug Resistance-Associated Protein 4 TransporterPharmaceutical Research, 2007
- Effect of Breast Cancer Resistance Protein (Bcrp/Abcg2) on the Disposition of PhytoestrogensMolecular Pharmacology, 2007
- Multidrug resistance-associated proteins 3, 4, and 5Pflügers Archiv - European Journal of Physiology, 2006
- Topotecan Is a Substrate for Multidrug Resistance Associated Protein 4Current Drug Metabolism, 2006
- Characterization of uremic toxin transport by organic anion transporters in the kidneyKidney International, 2004